Navigation Links
Silence Therapeutics Announces Subscription and Open Offer to Raise up to £5.7 Million
Date:7/11/2012

STATES.

Silence Therapeutics plc

("Silence" or the "Company")

Subscription and Open Offer of New Ordinary Shares

The Board of Silence is pleased to announce a Fundraising of up to £5.7 million (before expenses) through the issue of up to 840,000,000 New Ordinary Shares by way of a Subscription at 0.5 pence per Ordinary Share to certain investors and Directors and up to a further 100,019,847 New Ordinary Shares to be issued through an Open Offer at 0.5 pence per New Ordinary Share and the issue of a Convertible Loan Note of £1 million.  The Issue Price represents a discount of approximately 44 per cent. to the price of 0.89 pence per share, being the Closing Price of the Company's Ordinary Shares on 11 July 2012.  The Company also announces that it has entered into a £10 million Equity Finance Facility ("EFF"), conditional upon Admission, with Darwin Strategic Limited, a subsidiary of Alphagen Volantis Fund ("Henderson") part of the fund management group Henderson Global Investors ("Darwin").

The Fundraising is conditional, inter alia, upon the passing by Shareholders of certain Resolutions at the General Meeting (and is subject to the effect of the Share Capital Reorganisation).

The total amount that the Company could raise under the Fundraising is £5.7 million (before expenses), assuming all the Open Offer Entitlements are taken up.  The Subscription, the Open Offer and the Convertible Loan Note are not underwritten.

The circular (the "Circular") relating to the Subscription and Open Offer will be posted to shareholders today.  The Circular contains a notice of general meeting to approve, inter alia, the Subscription and Open Offer which will be held at the offices of Covington & Burling LLP, 265 Strand, London, WC2R 1BH at 10.00 a.m. on 31 July 2012.

The Circular will soon be available to view on the Company's website (
'/>"/>

SOURCE Silence Therapeutics Plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. Silence Therapeutics Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silences AtuRNAi in a New Indication
2. Silence Therapeutics Announces Board Changes and Appointment of New Chief Executive Officer
3. Silence Therapeutics Additional Listing
4. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
5. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
6. Nektar Therapeutics Announces Private Placement of $125 Million of Senior Secured Notes Due in 2017
7. Bio-Innovator Saneron CCEL Therapeutics Supports Cryo-Cell International Leadership and Board of Directors in Proxy Contest
8. Global Neuroendocrine Carcinoma Therapeutics Market To Reach $475m By 2019 - Report
9. United Therapeutics Announces Additional $100 Million Share Repurchase Program
10. Healthpoint Biotherapeutics To Create State-of-the-Art Cell Sciences Manufacturing Facility
11. ResearchMoz: Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar- Market Research Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... Massachusetts , September 2, 2014 ... to BioData,s research and lab management services  ... management service, is pleased to announce the appointment of ... Culot most recently served as VP Marketing and Business ... life science research and clinical applications. Previously, ...
(Date:9/1/2014)... 01, 2014 The Collaborative R&D ... report provides comprehensive understanding and unprecedented access to ... by the worlds leading life science companies. , ... of how and why companies enter collaborative R&D ... partner’s negotiated deals terms provides critical insight into ...
(Date:8/31/2014)... Dallas, Texas (PRWEB) August 31, 2014 ... on the current state of the Epoxy Hardener ... provides a basic overview of the industry, including ... analysis and Chinese domestic market analysis are provided ... competitive landscape of the market. A comparison between ...
(Date:8/29/2014)... Albany, New York (PRWEB) August 29, 2014 ... be valued at $5.6 billion in 2019. It ... 18.1% from 2013 to 2019, and was valued ... research report published by Transparency Market Research. , ... please visit: http://www.transparencymarketresearch.com/companion-diagnostics-market.html . , The research ...
Breaking Biology Technology:Louis Culot Appointed as BioData's CEO 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz.us 2Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz.us 3Collaborative R&D Terms & Agreements in Pharma, Biotech and Diagnostics Industry Analysis, Size, Share, Growth, Trends And Forecast Research Report by Researchmoz.us 4Epoxy Hardener Industry Development Trends in Global & China Regions Now Available at ReportsnReports.com 2Epoxy Hardener Industry Development Trends in Global & China Regions Now Available at ReportsnReports.com 3Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3
... Medarex, Inc. (Nasdaq: MEDX ) is ... at 8:30 a.m. Eastern Time on Thursday, April 30, ... for the first quarter of 2009.To access the call ... webcast can be accessed through the Investor Relations section ...
... Integrity Provider First to Bring IP Ownership into Discussion , ... ... LLC , the leading provider of data integrity solutions, announced today ... and only data integrity protection provider of its kind ...
... BioMS Medical Corp (TSX: MS), a leading developer in the ... Giese, President and CEO, will present at a session entitled ... technology sector" as part of the Alberta Economic Forum in ... Monday May 4th at 10:05am (Local time), ...
Cached Biology Technology:Medarex to Host Business and Financial Update Conference Call on Thursday, April 30, 2009 2Surety, LLC Joins Microsoft BioIT Alliance 2Surety, LLC Joins Microsoft BioIT Alliance 3BioMS Medical to present at Alberta Economic Forum in Geneva 2
(Date:9/2/2014)... Sam Kean stops by Reactions this week to debunk ... that, despite what "Shark Week" may lead you to ... http://youtu.be/KhFygIoW_MA . , Kean,s book, "The Disappearing Spoon: ... History of the World from the Periodic Table of ... 10-episode video series produced for the newly launched American ...
(Date:9/2/2014)... spiky legs and their propensity for eating anything, including ... And now research from North Carolina State University finds ... across the eastern United States. , "The good news ... kind of threat to humans," says Dr. Mary Jane ... author of a paper about the research. , The ...
(Date:9/2/2014)... N.C. -- When you accidentally touch a hot oven, ... the basic neural circuits involved in sensing and responding ... the molecular players. , Duke researchers have made a ... involved in pain in worms, and have built a ... 2 in Nature Communications , may help direct ...
Breaking Biology News(10 mins):Researchers find Asian camel crickets now common in US homes 2Surprising new role for calcium in sensing pain 2Surprising new role for calcium in sensing pain 3
... of Alzheimer,s disease reports improvement in language abilities ... the research, published today in the open access ... minutes of using this new treatment. Building ... in BioMed Central,s Journal of Neuroinflammation, ...
... to be the niche. As air and water preceded life, ... cells in many tissues and provides factors necessary to keep ... cell dependents. A team of scientists at the ... assistant professor in the Laboratory of Genetics, now suggests that ...
... the burgeoning field of interventional therapies for congenital ... Vegas July 20-23 for the Pediatric & Adult ... Medical Center in Chicago will perform live cases ... On Monday, July 21st, Dr. Ziyad M. ...
Cached Biology News:Stem cell chicken and egg debate moves to unlikely arena: the testes 2Stem cell chicken and egg debate moves to unlikely arena: the testes 3Latest advances in interventional cardiology for congenital heart disease presented 2
... and affinity purification of small components ... monodisperse magnetic particles (2.8 m in ... surface activation is not required. Allows ... orientation for affinity purification of proteins. ...
ZO-2 (H-110)...
p-Bcl-2 (Thr 74)...
Derlin-2 (C-18)...
Biology Products: